ixazomib,daratumumab
takeda,janssen
['multiplemyeloma', 'mmsm']
in this elderly frail population ixa-dara is a feasible combination with favorable efficacy profile even in len refractory and hr cytogenetic patients #asco22 #mmsm #multiplemyeloma ifm 2018-02 
Multiple Myeloma Education Platform for Myeloma Community